Thus, urinary citrate protects against calcium oxalate and uric acid kidney stones
Ethics statement The animal study was reviewed and approved by China Medical University
ProHealth BPC-157 is a dietary supplement, not an FDA-approved drug
These pharmacokinetic limitations explain why the most successful applications have been topical (where the peptide is applied directly to the target tissue) rather than systemic
The specific reasons identified include intensive insulin therapy, decreased renal function, severe liver disease, alcohol ingestion, defective counter regulatory hormone release, missing meals/fasting, and gastroparesis
There is no defined dose for therapeutic use in humans in scientific literature